Genetic-epigenetic tissue mapping for plasma DNA: applications in prenatal testing, transplantation and oncology

  1. Wanxia Gai
  2. Ze Zhou
  3. Sean Agbor-Enoh
  4. Xiaodan Fan
  5. Sheng Lian
  6. Peiyong Jiang
  7. Suk Hang Cheng
  8. John Wong
  9. Stephen Lam Chan
  10. Moon Kyoo Jang
  11. Yanqin Yang
  12. Raymond H S Liang
  13. Wai Kong Chan
  14. Edmond S K Ma
  15. Tak Y Leung
  16. Rossa W K Chiu
  17. Hannah Valantine
  18. K C Allen Chan
  19. Y M Dennis Lo  Is a corresponding author
  1. The Chinese University of Hong Kong, Hong Kong
  2. Johns Hopkins School of Medicine, United States
  3. National Heart, Lung and Blood Institute, United States
  4. Hong Kong Sanatorium and Hospital, Hong Kong

Abstract

We developed Genetic-Epigenetic Tissue Mapping (GETMap) to determine the tissue composition of plasma DNA carrying genetic variants not present in the constitutional genome through comparing their methylation profiles with relevant tissues. We validated this approach by showing that, in pregnant women, circulating DNA carrying fetal-specific alleles was entirely placenta-derived. In lung-transplant recipients, we showed that, at 72 hours after transplantation, the lung contributed only a median of 17% to the plasma DNA carrying donor-specific alleles and hematopoietic cells contributed a median of 78%. In hepatocellular cancer patients, the liver was identified as the predominant source of plasma DNA carrying tumor-specific mutations. In a pregnant woman with lymphoma, plasma DNA molecules carrying cancer mutations and fetal-specific alleles were accurately shown to be derived from the lymphocytes and placenta, respectively. Analysis of tissue origin for plasma DNA carrying genetic variants is potentially useful for noninvasive prenatal testing, transplantation monitoring and cancer screening.

Data availability

Sequencing data have been deposited in EGA under the accession code EGAS00001004788.

The following data sets were generated

Article and author information

Author details

  1. Wanxia Gai

    Chemical Pathology, The Chinese University of Hong Kong, Shatin, Hong Kong
    Competing interests
    No competing interests declared.
  2. Ze Zhou

    Chemical Pathology, The Chinese University of Hong Kong, Shatin, Hong Kong
    Competing interests
    No competing interests declared.
  3. Sean Agbor-Enoh

    Division of Pulmonary and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, United States
    Competing interests
    No competing interests declared.
  4. Xiaodan Fan

    Department of Statistics, The Chinese University of Hong Kong, Shatin, Hong Kong
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2744-9030
  5. Sheng Lian

    Statistics, The Chinese University of Hong Kong, Shatin, Hong Kong
    Competing interests
    No competing interests declared.
  6. Peiyong Jiang

    Chemical Pathology, The Chinese University of Hong Kong, Shatin, Hong Kong
    Competing interests
    Peiyong Jiang, Holds equities in Grail.Serves as a director of KingMed Future.Received patent royalties from Grail, Illumina, Sequenom, DRA, Take2 and Xcelom.Filed a patent application (US15/214,998)..
  7. Suk Hang Cheng

    Chemical Pathology, The Chinese University of Hong Kong, Shatin, Hong Kong
    Competing interests
    No competing interests declared.
  8. John Wong

    Surgery, The Chinese University of Hong Kong, Shatin, Hong Kong
    Competing interests
    No competing interests declared.
  9. Stephen Lam Chan

    Department of Clinical Oncology, The Chinese University of Hong Kong, Hong Kong, Hong Kong
    Competing interests
    No competing interests declared.
  10. Moon Kyoo Jang

    Division of Intramural Research, National Heart, Lung and Blood Institute, Bethesda, United States
    Competing interests
    No competing interests declared.
  11. Yanqin Yang

    Division of Intramural Research, National Heart, Lung and Blood Institute, Bethesda, United States
    Competing interests
    No competing interests declared.
  12. Raymond H S Liang

    Comprehensive Oncology Centre, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong
    Competing interests
    No competing interests declared.
  13. Wai Kong Chan

    Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong
    Competing interests
    No competing interests declared.
  14. Edmond S K Ma

    Pathology, Hong Kong Sanatorium and Hospital, Happy Valley, Hong Kong
    Competing interests
    No competing interests declared.
  15. Tak Y Leung

    Obstetrics and Gynaecology, The Chinese University of Hong Kong, Shatin, Hong Kong
    Competing interests
    No competing interests declared.
  16. Rossa W K Chiu

    Chemical Pathology, The Chinese University of Hong Kong, Shatin, Hong Kong
    Competing interests
    Rossa W K Chiu, Holds equities in DRA, Take2 and Grail.Is a consultant to Grail and Illumina.Receives research funding from Grail.Receives royalties from Grail, Illumina, Sequenom, DRA, Take2 and Xcelom.Filed a patent application (US15/214,998)..
  17. Hannah Valantine

    Division of Intramural Research, National Heart, Lung and Blood Institute, Bethesda, United States
    Competing interests
    No competing interests declared.
  18. K C Allen Chan

    Chemical Pathology, The Chinese University of Hong Kong, Shatin, Hong Kong
    Competing interests
    K C Allen Chan, Holds equities in DRA, Take2 and Grail.Is a consultant to and receives research funding from Grail.Receives royalties from Grail, Illumina, Sequenom, DRA, Take2 and Xcelom.Filed a patent application (US15/214,998)..
  19. Y M Dennis Lo

    Department of Chemical Pathology, The Chinese University of Hong Kong, Hong Kong, Hong Kong
    For correspondence
    loym@cuhk.edu.hk
    Competing interests
    Y M Dennis Lo, Reviewing editor, eLife.Holds equities in DRA, Take2 and Grail.Is a consultant, scientific cofounder and scientific advisory board member of Grail.Received patent royalties from Grail, Illumina, Sequenom, DRA, Take2 and Xcelom.Had filed a patent application (US15/214,998)..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-8746-0293

Funding

Research Grants Council, University Grants Committee (Theme-based research scheme T12-403/15-N)

  • Rossa W K Chiu
  • K C Allen Chan
  • Y M Dennis Lo

Research Grants Council, University Grants Committee (Theme-based research scheme T12-401/16-W)

  • Rossa W K Chiu
  • K C Allen Chan
  • Y M Dennis Lo

Chinese University of Hong Kong (VCF2014021)

  • Rossa W K Chiu
  • K C Allen Chan
  • Y M Dennis Lo

Grail (Collaborative research agreement)

  • Rossa W K Chiu
  • K C Allen Chan
  • Y M Dennis Lo

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: The project was approved by the Joint Chinese University of Hong Kong-Hospital Authority New Territories East Cluster Clinical Research Ethics Committee (approval reference number 2011.204). All participants provided written informed consent.

Copyright

This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.

Metrics

  • 2,815
    views
  • 393
    downloads
  • 21
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Wanxia Gai
  2. Ze Zhou
  3. Sean Agbor-Enoh
  4. Xiaodan Fan
  5. Sheng Lian
  6. Peiyong Jiang
  7. Suk Hang Cheng
  8. John Wong
  9. Stephen Lam Chan
  10. Moon Kyoo Jang
  11. Yanqin Yang
  12. Raymond H S Liang
  13. Wai Kong Chan
  14. Edmond S K Ma
  15. Tak Y Leung
  16. Rossa W K Chiu
  17. Hannah Valantine
  18. K C Allen Chan
  19. Y M Dennis Lo
(2021)
Genetic-epigenetic tissue mapping for plasma DNA: applications in prenatal testing, transplantation and oncology
eLife 10:e64356.
https://doi.org/10.7554/eLife.64356

Share this article

https://doi.org/10.7554/eLife.64356

Further reading

    1. Medicine
    2. Neuroscience
    Emily M Adamic, Adam R Teed ... Sahib Khalsa
    Research Article

    Interactions between top-down attention and bottom-up visceral inputs are assumed to produce conscious perceptions of interoceptive states, and while each process has been independently associated with aberrant interoceptive symptomatology in psychiatric disorders, the neural substrates of this interface are unknown. We conducted a preregistered functional neuroimaging study of 46 individuals with anxiety, depression, and/or eating disorders (ADE) and 46 propensity-matched healthy comparisons (HC), comparing their neural activity across two interoceptive tasks differentially recruiting top-down or bottom-up processing within the same scan session. During an interoceptive attention task, top-down attention was voluntarily directed towards cardiorespiratory or visual signals. In contrast, during an interoceptive perturbation task, intravenous infusions of isoproterenol (a peripherally-acting beta-adrenergic receptor agonist) were administered in a double-blinded and placebo-controlled fashion to drive bottom-up cardiorespiratory sensations. Across both tasks, neural activation converged upon the insular cortex, localizing within the granular and ventral dysgranular subregions bilaterally. However, contrasting hemispheric differences emerged, with the ADE group exhibiting (relative to HCs) an asymmetric pattern of overlap in the left insula, with increased or decreased proportions of co-activated voxels within the left or right dysgranular insula, respectively. The ADE group also showed less agranular anterior insula activation during periods of bodily uncertainty (i.e. when anticipating possible isoproterenol-induced changes that never arrived). Finally, post-task changes in insula functional connectivity were associated with anxiety and depression severity. These findings confirm the dysgranular mid-insula as a key cortical interface where attention and prediction meet real-time bodily inputs, especially during heightened awareness of interoceptive states. Furthermore, the dysgranular mid-insula may indeed be a ‘locus of disruption’ for psychiatric disorders.

    1. Medicine
    Yanling Huang, Haocong Mo ... Geyang Xu
    Research Article

    Glucagon-like peptide 1 (GLP-1) is a gut-derived hormone secreted by intestinal L cells and vital for postprandial glycemic control. As open-type enteroendocrine cells, whether L cells can sense mechanical stimuli caused by chyme and thus regulate GLP-1 synthesis and secretion is unexplored. Molecular biology techniques revealed the expression of Piezo1 in intestinal L cells. Its level varied in different energy status and correlates with blood glucose and GLP-1 levels. Mice with L cell-specific loss of Piezo1 (Piezo1 IntL-CKO) exhibited impaired glucose tolerance, increased body weight, reduced GLP-1 production and decreased CaMKKβ/CaMKIV-mTORC1 signaling pathway under normal chow diet or high-fat diet. Activation of the intestinal Piezo1 by its agonist Yoda1 or intestinal bead implantation increased the synthesis and secretion of GLP-1, thus alleviated glucose intolerance in diet-induced-diabetic mice. Overexpression of Piezo1, Yoda1 treatment or stretching stimulated GLP-1 production and CaMKKβ/CaMKIV-mTORC1 signaling pathway, which could be abolished by knockdown or blockage of Piezo1 in primary cultured mouse L cells and STC-1 cells. These experimental results suggest a previously unknown regulatory mechanism for GLP-1 production in L cells, which could offer new insights into diabetes treatments.